DrugPatentWatch.com Announces New Drug Patent Expiration Website

New website features detailed information on pharmaceutical drugs and their patent expirations

Washington, DC, October 28, 2009 --(PR.com)-- DrugPatentWatch.com announces a new website featuring detailed information on pharmaceutical drugs and their patent expirations.

This new website features comprehensive information on pharmaceutical companies, their products, and the patents covering them.

Datasets include:
- Impending drug patent expirations
- Annual sales
- Drug therapeutic class
- Paragraph IV challenges
- Premature patent expiration due to lack of maintenance fee payment
- Patent reexaminations
- Patent interferences
- Patent disclaimers
- Full-text drug patent PDFs
- Drug patent claim types (use, compound, formulation, etc.)

Detailed previews and a site tour are available at http://www.DrugPatentWatch.com

###

About DrugPatentWatch.com
DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. This value-added information supports the critical business functions of patent agents and attorneys, generic and branded pharmaceutical companies, wholesalers, healthcare payers, and investors.
Contact
DrugPatentWatch.com
Yali Friedman
202-487-0089
www.DrugPatentWatch.com
ContactContact
Categories